MSC's can be derived from a variety of adult tissues including bone marrow, skeletal muscle, adipose tissue, and synovium. Recent findings have indicated that MSC's from different tissues of origin have divergent capability profiles in their ability to undergo chondrogenesis, osteogenesis, and adipogenesis. Studies have yet to investigate these differences with respect to tenogenesis or the effect of tenogenic growth factors between these cell types.
This study seeks to address three aims: (1) to identify whether a difference exists between bone marrow derived stromal cells and skeletal muscle derived stromal cells with respect to their ability to be isolated from their tissues of origin and undergo expansion in culture, (2) to evaluate if a discrepancy exists between these two stromal cell populations in their ability to differentiate into Tenocytes, (3) to determine if tenogenesis in these cell types can be preferentially augmented by addition of growth and differentiation factor-5 (GDF-5).
MATERIALS AND METHODS:
Skeletal muscle harvest and bone marrow aspiration were performed on the hind limbs of six and seven, female, mongrel hounds, respectively. All experiments were conducted in accordance with the Institutional Animal Care and Use Committee guidelines. Bone marrow samples were passaged in culture to achieve stromal cell expansion. Skeletal muscle samples were digested with collagenase II and similarly passaged. Following total RNA extraction, cDNA was successfully synthesized from the skeletal muscle tissue of 6 dogs and from skeletal muscle derived stromal cell samples and bone marrow derived stromal cell samples of 5 dogs each, to compare expression levels of myosin and CD44.
Following a fourth passage in culture, samples were induced toward tenogenesis utilizing two culture conditions employing either ascorbic acid alone or in conjunction GDF-5. Total RNA was extracted from each sample prior to induction, and following 7 and 14 days of induction. cDNA was synthesized and RT-PCR was performed to measure and compare expression of, tenomodulin (TNMD), collagen type 1 (COL1) and collagen type 3 (COL3) from the skeletal muscle derived stromal cells of 5 dogs and bone marrow derived stromal cells of 4 dogs. Two sets of post induction libraries were constructed at each time point following induction, as there were two separate culture conditions that were being observed.
HPRT was used as an internal control gene for RT-PCR. Relative expression levels were compared using the 2 -∆∆CT method. The effects of stromal cell origin and GDF-5 media augmentation on relative expression were evaluated using a linear mixed model in which cell type and growth factor were modeled as fixed effects, and dog ID was incorporated as a random effect. The models were fit using the SAS procedure PROC MIXED (SAS Institute Inc., Cary, NC).
RESULTS:
Following three passages in culture, the mean absolute expression of myosin in skeletal muscle derived stromal cells was undetectable when compared to skeletal muscle tissue (p < 0.001). Bone marrow derived stromal cells also demonstrated undetectable expression when compared to skeletal muscle tissue (p < 0.001). The difference in the relative expression of myosin between skeletal muscle derived stromal cells and bone marrow derived stromal cells at this time point was not found to be statistically significant (p = 0.20).
Also noted following three passages in culture, skeletal muscle derived stromal cells had a mean absolute expression of CD44 that was 48.28 times greater than that of skeletal muscle tissue (p = 0.002). Bone marrow derived stromal cells had a mean absolute expression of CD44 that was 20.74 times greater than that of skeletal muscle tissue (p = 0.007). The difference in the relative expression of CD44 between skeletal muscle derived stromal cells and bone marrow derived stromal cells at this time point was not found to be statistically significant (p = 0.17).
Seven and fourteen days following induction of tenogenesis, the mean relative expression of tenomodulin observed in skeletal muscle derived stromal cells was 0.26 and 26.31 times that of pre-induction expression, respectively. The mean relative expression of tenomodulin observed in bone marrow derived stromal cells at these time points was 0.78 and 1.39 times that of pre-induction expression, respectively. There was no statistically significant difference between the mean relative expression levels of tenomodulin when comparing stromal cells of different origins at either time point.
Skeletal muscle derived stromal cell expression of collagen type 1, measured at 7 and 14 days following induction, was 0.07 and 3.01 times that of pre-induction expression, respectively. Bone marrow stromal cells showed a significantly greater increase in collagen type 1 expression at these time points, reaching 3.30 and 6.81 times that of preinduction expression levels (p = 0.02 for day 7 and p = 0.03 for day 14). Collagen type 3 expression in skeletal muscle derived stromal cells on day 7 and 14 was 0.06 and 2.15 times that of pre-induction expression, respectively. Bone marrow stromal cells showed a significantly greater increase in collagen type 3 expression at these time points as well, reaching 1.99 and 5.51 times that of pre-induction expression levels (p = 0.003 for day 7 and p = 0.006 for day 14).
The addition of GDF-5 to the tenogenesis induction media did not have a significant effect on the expression of tenomodulin, collagen type 1, or collagen type 3 following 7 or 14 days of exposure, when comparing stromal cells originating from the same tissue.
DISCUSSION:
Mesenchymal stromal cells were extracted from skeletal muscle tissue and, following three passages in culture, showed an expression profile of myosin and CD44 that was not significantly different from bone marrow derived stromal cells. Following induction of tenogenesis, both stromal cell types showed an increase in expression of tenomodulin, collagen type 1, and collagen type 3 at 14 days, indicating tenocytic differentiation. While there was no significant difference in tenomodulin expression between the two stromal cell types, muscle derived stromal cells did have a higher expression that trended toward significance with a p value of 0.0611. The small sample size and large variability between RT-PCR samples resulted in limited statistical power to detect differences. Bone marrow stromal cells had a significantly higher relative expression of both matrix protein genes. Growth factor augmentation with GDF-5 did not have a statistically significant affect on gene expression. This may be due to another limitation of our study in that human recombinant GDF-5 was used to stimulate canine stromal cells, and the desired level of cross reactivity may not have occurred. Further studies applying external, mechanical stimuli to these stromal cells within a scaffold may help to further characterize their respective tenogenic capabilities.
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